David R. Gandara
Comprehensive Blood & Cancer Center(US)Bandung Islamic University(ID)University of California Davis Medical Center(US)UC Davis Comprehensive Cancer CenterUniversity of California, Davis(US)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Lung Cancer Research Studies, Cancer Genomics and Diagnostics, Lung Cancer Diagnosis and Treatment, Colorectal Cancer Treatments and Studies
Most-Cited Works
- → Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial(2016)4,726 cited
- → Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer(2008)3,206 cited
- → Vinorelbine plus Cisplatin vs. Observation in Resected Non–Small-Cell Lung Cancer(2005)1,822 cited
- → Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial(2009)1,460 cited
- → Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial(2015)1,421 cited
- →